Systematic Reviews Open Access
Copyright ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Jul 15, 2021; 13(7): 732-757
Published online Jul 15, 2021. doi: 10.4251/wjgo.v13.i7.732
Laparoscopic liver resection for colorectal liver metastases — short- and long-term outcomes: A systematic review
Emily Taillieu, Celine De Meyere, Frederiek Nuytens, Mathieu D'Hondt, Department of Digestive and Hepatobiliary/Pancreatic Surgery, AZ Groeninge, Kortrijk 8500, Belgium
Chris Verslype, Department of Gastroenterology and Hepatology, KU Leuven, Leuven 3000, Belgium
ORCID number: Emily Taillieu (0000-0002-2825-1595); Celine De Meyere (0000-0002-5116-0376); Frederiek Nuytens (0000-0003-1194-0981); Chris Verslype (0000-0003-3857-466X); Mathieu D'Hondt (0000-0001-5542-3017).
Author contributions: Taillieu E Performed the research, acquired the data, analyzed the data, wrote the paper; De Meyere C and Nuytens F supervised the paper; Verslype C and D’Hondt M designed the research, supervised the paper.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
PRISMA 2009 Checklist statement: The authors have read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Mathieu D'Hondt, MD, Doctor, Department of Digestive and Hepatobiliary/Pancreatic Surgery, AZ Groeninge, President Kennedylaan 4, Kortrijk 8500, Belgium. mathieudhondt2000@yahoo.com
Received: January 4, 2021
Peer-review started: January 4, 2021
First decision: May 3, 2021
Revised: May 16, 2021
Accepted: June 25, 2021
Article in press: June 25, 2021
Published online: July 15, 2021

Abstract
BACKGROUND

For well-selected patients and procedures, laparoscopic liver resection (LLR) has become the gold standard for the treatment of colorectal liver metastases (CRLM) when performed in specialized centers. However, little is currently known concerning patient-related and peri-operative factors that could play a role in survival outcomes associated with LLR for CRLM.

AIM

To provide an extensive summary of reported outcomes and prognostic factors associated with LLR for CRLM.

METHODS

A systematic search was performed in PubMed, EMBASE, Web of Science and the Cochrane Library using the keywords “colorectal liver metastases”, “laparoscopy”, “liver resection”, “prognostic factors”, “outcomes” and “survival”. Only publications written in English and published until December 2019 were included. Furthermore, abstracts of which no accompanying full text was published, reviews, case reports, letters, protocols, comments, surveys and animal studies were excluded. All search results were saved to Endnote Online and imported in Rayyan for systematic selection. Data of interest were extracted from the included publications and tabulated for qualitative analysis.

RESULTS

Out of 1064 articles retrieved by means of a systematic and grey literature search, 77 were included for qualitative analysis. Seventy-two research papers provided data concerning outcomes of LLR for CRLM. Fourteen papers were eligible for extraction of data concerning prognostic factors affecting survival outcomes. Qualitative analysis of the collected data showed that LLR for CRLM is safe, feasible and provides oncological efficiency. Multiple research groups have reported on the short-term advantages of LLR compared to open procedures. The obtained results accounted for minor LLR, as well as major LLR, simultaneous laparoscopic colorectal and liver resection, LLR of posterosuperior segments, two-stage hepatectomy and repeat LLR for CRLM. Few research groups so far have studied prognostic factors affecting long-term outcomes of LLR for CRLM.

CONCLUSION

In experienced hands, LLR for CRLM provides good short- and long-term outcomes, independent of the complexity of the procedure.

Key Words: Laparoscopic liver resection, Colorectal liver metastases, Outcomes, Prognostic factors, Systematic review

Core Tip: Laparoscopic liver surgery has been widely adopted over the last few years. Meanwhile, laparoscopic liver resection (LLR) has become the gold standard for the treatment of colorectal liver metastases (CRLM) in specialized centers and for well-selected patients and procedures. However, little is known concerning patient-related and peri-operative factors potentially playing a role in survival outcomes associated with LLR for CRLM. The aim of this systematic review is to provide an extensive summary of reported outcomes and prognostic factors associated with LLR for CRLM.



INTRODUCTION

Colorectal cancer (CRC) is the third most common malignancy in terms of incidence worldwide and the fourth most common cause of cancer death[1,2]. The most frequent cause of death in CRC patients is metastatic disease[3,4], with the liver being the most common site of metastasis[2,3]. The risk for these patients to develop colorectal liver metastases (CRLM) is up to 50%[2,4-7]. A liver resection (LR) in this context is the only treatment option that can provide a potential cure[2,4,5], with reported 5-year survival rates that vary between 35% and 60%[8]. Despite a high rate of irresectability at initial presentation, advances in the field of liver surgery and the emergence of multidisciplinary approaches in the last couple of decades have led to significant improvements in long-term outcome[5].

Many studies that have been published lately have attempted to elucidate the safety and feasibility of laparoscopic liver resection (LLR) for CRLM, along with its role in the treatment sequence of these patients. Most often, these reports have compared outcomes between LLR and open liver resection (OLR). Randomized controlled trials (RCT) and meta-analyses have shown equal or better short-term outcomes after LLR compared to OLR along with equivalent oncologic outcomes[8-19]. One of these meta-analyses of propensity-score matched studies and RCTs unexpectedly showed a survival advantage favoring LLR over OLR when indicated for CRLM[13]. Little is known however concerning patient-related and peri-operative factors that could play a role in survival outcomes after LLR for CRLM and how these variables in turn could be applied as prognostic factors. As such, for this systematic review, all currently available literature was screened for articles that reported on short- and long-term outcomes following LLR for CRLM along with studies that have analyzed potential prognostic factors (demographics, pre-, intra- and postoperative factors) affecting survival outcomes after LLR for CRLM.

MATERIALS AND METHODS

This systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist of 2009[20].

Search strategy

A systematic search was performed in PubMed, EMBASE, Web of Science and the Cochrane Library from inception until December 24, 2019 (which was the start date of the performance of the search strategy). The search strategy consisted of breaking up the research question “short- and long-term outcomes following laparoscopic liver resection for colorectal liver metastases and prognostic factors” into separate concepts that fit the PICO (Patient-Intervention-Comparison-Outcome) model: “Colorectal liver metastases” for Patient, “laparoscopy” and “liver resection” for Intervention and “prognostic factors, outcomes and survival” for Outcome. Within the context of this systematic review, “Comparison” was not applicable in the PICO-model. In PubMed, the most appropriate medical subject headings (MeSH) terms were chosen, including "Laparoscopy" AND "Hepatectomy" AND "Colorectal Neoplasms" AND "Prognosis" OR "Survival" OR "Outcome Assessment (Health Care)" OR "Treatment Outcome". The MeSH terms were searched for within the title and the abstract, as were all the corresponding synonyms. The same strategy was applied in EMBASE by means of Emtree terms, including 'laparoscopy' AND 'liver resection' AND 'colorectal liver metastasis' AND 'prognosis' OR 'survival' OR 'outcome assessment' OR 'treatment outcome' OR 'short term outcome' OR 'long term outcome'. The Emtree terms and the corresponding synonyms were searched for within the title, abstract and keywords. The terms included in both search strategies were aligned to obtain as many results as possible in both databases. The final, aligned search strategy was adopted for the Web of Science database and the Cochrane Library database.

Inclusion criteria

For the collection of outcome data: (1) Publications needed to report the result of at least one short- or long-term outcome following LLR; (2) The indication for resection had to be CRLM; and (3) A study cohort of at least 20 patients undergoing LLR needed to be included (to ensure reliability of the studies).

For the collection of data on prognostic factors: (1) Publications needed to report at least one factor (demographic/preoperative/intraoperative/postoperative) to be studied for correlation with a (or multiple) survival outcome(s) of (L)LR together with the associated correlation; (2) The indication for resection had to be CRLM; and (3) A study cohort of at least 20 patients needed to be included (again to ensure reliability of the studies).

In case of multiple studies providing duplicated or the same data, only the most recent study was included. Furthermore, only publications written in English were included.

Abstracts of which no accompanying full text was published, reviews, case reports, letters, protocols, comments, surveys, animal studies, outcome studies that only described treatment procedures other than pure LLR (e.g., chemotherapy regimens, ablation techniques, hand-assisted LLR, robotic LLR) and studies that only described pathologies other than CRLM (e.g., non-colorectal liver metastases) were excluded.

The in- and exclusion criteria were based on those found in already existing literature[18,21,22].

Selection of search results

All of the search results were saved to Endnote Online and imported into Rayyan, a web and mobile app for systematic reviews[23]. Deduplication of the search results was first done automatically in Endnote Online and was followed by further manual deduplication in Rayyan. The remaining articles were first screened based on title and abstract according to the presupposed in- and exclusion criteria. An informal grey literature search was performed, and these articles were also subjected to screening of the title and abstract. Thereafter, a full-text analysis was performed until all included articles only contained relevant studies.

Data extraction

After full-text analysis, the data relevant for this research were tabulated. This was done separately for research concerning outcomes and research concerning prognostic factors.

For research concerning outcomes, as much of the following data as possible (depending on the data examined in a particular study) were extracted and tabulated for analysis: Study data (title, first author, year of publication, country, study design, number of patients who underwent LLR), patient demographic data (age and sex), intraoperative data (conversion rate, rate of major hepatectomies, operative time, blood loss, operative death and rate of need for blood transfusion), postoperative short-term outcomes (30 d mortality, 30 d morbidity, duration of hospital stay, length of stay at high-dependency unit or intensive care unit, overall rate of postoperative complications, rate of major postoperative complications, rate of need for postoperative blood transfusion, 90 d mortality and time to chemotherapy), characteristics of lesions and resection margins (rates of 1/2/≥ 3 Lesions/specimen, number of lesions, diameter of lesions, size of largest lesion, R1 and R0 resection rates and tumor free resection margin), long-term outcomes (follow-up (FU) duration, recurrence rate, rate of deaths during FU, median/mean survival, 1-, 2-, 3-, 4-, 5-, 7- and 10-year overall survival (OS), disease free survival (DFS) and recurrence free survival (RFS), median DFS and median RFS) and general conclusions about safety, feasibility, effectivity and oncological efficiency. When articles reported data of LLR for CRLM in a specific context (major/minor hepatectomy, LLR of posterosuperior segments, parenchyma sparing LLR, simultaneous laparoscopic colorectal and liver resection, two-stage hepatectomy (TSH) or repeat LLR), outcomes were collected in a subgroup to easily analyze those data within the particular context.

For research concerning prognostic factors, the following data were extracted and tabulated for analysis: Study data (title, first author, year of publication, country, study design, number of patients included, whether or not the study is specific for LLR), patient demographic data (age and sex), the prognostic factor(s), the corresponding correlate(s), and the associated relationship.

In case of propensity score-matched studies, a decision was made to collect data either from the cohort before or after matching in function of which cohort represented more relevant data. In case of stratification, e.g., based on a cut-off at a certain age or a certain tumor size, where the stratification was reported to make no difference in any outcome, and where the general data of the whole cohort was provided, it was decided to collect the reported data of the whole cohort. Otherwise, data were collected of the most relevant group of which the most relevant data were reported. All texts, tables and figures of relevance were reviewed for data extraction.

Data presentation and analysis

After data collection, a selection was made of the gathered outcomes based on relevance and the number of times they were reported. The selected outcomes were comprised in tables in which all data of the included articles were tabulated. These tables were analyzed merely qualitatively and discussed in general. Incoherent data or data that seemed to deviate from the other reports were verified in the original article to check for any specific causes explaining the deviation.

RESULTS
Publication selection and characteristics

Application of the aforementioned search strategy in PubMed, EMBASE, Web of Science and the Cochrane Library resulted in 1061 publications. After deduplication, there were 673 publications left for screening. After screening based on title and abstract, 173 articles were withheld. An informal grey literature search yielded another 3 articles of which the title and abstract seemed to possibly meet the in- and exclusion criteria. All full-text articles were obtained and screened thoroughly for eligibility (based on in- and exclusion criteria), after which extensive data extraction was performed. Reasons to exclude publications during full-text analysis were: Only an abstract was available, outcome studies did not provide any CRLM data or LLR data, outcome studies did not report any of the selected relevant outcomes, studies reported risk factors affecting outcomes that were not prognostic factors, the study cohort consisted of less than 20 patients or no English text was available. This led to a final total of 77 publications for inclusion in the review, and thus, for data extraction. Figure 1 provides a summary of the publication selection process. Tables 1 and 2 provide an overview of the study details of the included studies for data concerning outcomes and prognostic factors, respectively.

Figure 1
Figure 1 Flow diagram of the systematic review selection process. Adapted from Ref.[20].
Table 1 Study details of studies concerning outcomes.
Ref.YearCountryStudy designNumber of patientsAge in yr
Abu Hilal et al[24]2012United KingdomRetrosp.8366 (32-85)
Abu Hilal et al[71]2010United KingdomRetrosp.5066 (17)1
Allard et al[60]2015FranceRetrosp., PSM17665.1 ± 11
Barkhatov et al[25]2016NorwayRetrosp.14469 (30-89)
Beard et al[43]2015United StatesRetrosp., PSM11561 ± 12
Beppu et al[72]2015JapanRetrosp., PSM171-
Berardi et al[73]2017Belgium, Norway, United Kingdom, ItalyRetrosp.1048-
Castaing et al[32]2009FranceRetrosp.6062 ± 11
Chen et al[74]2018ChinaRetrosp.156-
Cheung et al[48]2013ChinaRetrosp., case-matched control2057.5 (42-74)
Cipriani et al[75]2015United KingdomRetrosp.142-
Cipriani et al[29]2016United KingdomRetrosp., PSM133-
D’Hondt et al[76]2018BelgiumRetrosp.136-
de’Angelis et al[44]2015FranceRetrosp., PSM5263 (32-81)
Efanov et al[77]2018RussiaRetrosp., PSM60-
Eveno et al[78]2016France, Spain, United Kingdom, Germany, Canada, SwitzerlandRetrosp., PSM585-
Fretland et al[12]2019NorwayRCT133-
Fretland et al[9]2018NorwayRCT13367 ± 8
Goumard et al[45]2018United StatesRetrosp., PSM4359 (26-78)
Guerron et al[50]2013United StatesRetrosp.4066.2 ± 1.9
Hirokawa et al[79]2014United StatesRetrosp., matched-pair46-
Inoue et al[80]2013JapanRetrosp.2366.1 ± 9.6
Iwahashi et al[81]2014United StatesRetrosp., matched-pair2167.5 (47-92)
Karagkounis et al[46]2016United StatesRetrosp., case-control6564 (54-71)1
Kasai et al[82]2018BelgiumRCT2065.2 (40.4-86.1)
Kazaryan et al[26]2010NorwayRetrosp.107-
Kazaryan et al[83]2010NorwayRetrosp.96-
Kubota et al[51]2014JapanRetrosp.4364.4 ± 11.4
Langella et al[52]2015ItalyRetrosp., case-control3763 (37-86)
Lewin et al[84]2016AustraliaRetrosp., PSM146-
Martínez-Cecilia et al[30]2017United Kingdom, Italy, France, Belgium, NorwayRetrosp., PSM22575 (70-87)1
Nguyen et al[31]2009United States, FranceRetrosp.10963 (32-88)
Nomi et al[27]2016France, JapanRetrosp., case-matched12061 (26-89)
Postriganova et al[28]2014NorwayRetrosp.15566 (35-84)
Qiu et al[41]2013ChinaRetrosp., comparative cohort3052.5 ± 11.5
Ratti et al[53]2018ItalyRetrosp., PSM10462 (35-81)
Robles-Campos et al[49]2019SpainRCT9666 (58-72)1
Shelat et al[85]2015SingaporeRetrosp.22-
Shim et al[54]2018South KoreaRetrosp.2265.5 ± 8.9
Tabchouri et al[70]2018FranceRetrosp.30264.4 ± 11.1
Tohme et al[55]2015United StatesRetrosp., case-matched6662.1 (11.2)1
Topal et al[86]2012BelgiumRetrosp.8164.3 (35.4-83)
Vibert et al[87]2006FranceRetrosp.37-
Yue et al[39]2018ChinaRetrosp.7874 (70-78)
Yun et al[88]2012South KoreaRetrosp.23-
Zeng et al[56]2016ChinaRetrosp., PSM7969 (65-75)
Andorra et al[89]2013SpainRetrosp.21-
Abu Hilal et al[90]2011United KingdomRetrosp., case-control2164 (26-82)
Nomi et al[57]2015FranceRetrosp., case-matched9364 (32-85)
Topal et al[58]2013BelgiumRetrosp., case-matched20-
Vavra et al[63]2015Czech Republic, United KingdomProsp., cohort2562.1 ± 10.3
Montalti et al[91]2016BelgiumRetrosp., PSM44-
Okuno et al[42]2018United StatesRetrosp., PSM2954 (27-78)
Portigliotti et al[92]2017France, ItalyRetrosp.7862.3 (37.8-86.0)
Scuderi et al[93]2017Belgium, Norway, Italy, United Kingdom, Spain, FranceRetrosp., PSM49-
Efanov et al[94]2020RussiaRetrosp. PSM5159 (41-84)
Aghayan et al[47]2017NorwayRetrosp.29666 (29-89)
Montalti et al[33]2015BelgiumRetrosp.11466.4 ± 0.89
Okumura et al[95]2019FranceRetrosp., PSM8265 (33-83)
Martínez-Cecilia et al[62]2018United Kingdom, SpainRetrosp.21-
Berti et al[40]2015GermanyRetrosp.3571 (35-82)
Dagher et al[61]2016United StatesRetrosp., PSM8966.6 ± 10.8
Ferretti et al[64]2015France, United States, Italy, South KoreaRetrosp.14266 (32-85)
Jung et al[96]2014South KoreaRetrosp., case-match2460 (43-75)
Ratti et al[65]2016ItalyRetrosp., PSM2560 (37-80)
Shin et al[34]2019South KoreaRetrosp., PSM10956 ± 11
van der Poel et al[97]2019The Netherlands, BelgiumRetrosp., PSM6164 ± 13.1
Xu et al[35]2018ChinaRetrosp. PSM2058.2 ± 10.66
Okumura et al[59]2019FranceRetrosp., PSM3862 (32-85)
Nomi et al[36]2016FranceRetrosp.208-
Hallet et al[37]2017FranceRetrosp,. PSM2763.6 (59.0-70.9)
van der Poel et al[38]2019United KingdomRetrosp., PSM27163 ± 11
Table 2 Study details of studies concerning prognostic factors.
Ref.YearCountryStudy designSpecific for LLR?Number of patientsAge in yr
Langella et al[52]2015ItalyRetrosp., case-controlNo74-
Nomi et al[27]2016France, JapanRetrosp., case-matchedYes12061 (26-89)
Postriganova et al[28]2014NorwayRetrosp.Yes15566 (35-84)
Tabchouri et al[70]2018FranceRetrosp.Yes30264.4 ± 11.1
Tohme et al[55]2015United StatesRetrosp., case-matchedNo132-
Topal et al[86]2012BelgiumRetrosp.No274-
Yue et al[39]2018ChinaRetrosp.Yes241-
Zeng et al[56]2016ChinaRetrosp., PSMNo158-
Montalti et al[33]2015BelgiumRetrosp.Yes11466.4 ± 0.89
Cervantes et al[98]2019FranceRetrosp.Yes227-
De Haas et al[99]2009The NetherlandsRetrosp.No796-
Jones et al[100]2014United KingdomRetrosp. cohortNo, only open7369.1 (59.8-73.9)1
Ratti et al[101]2019France, ItalyRetrosp., PSMYes146-
Nieropet al[102]2019The Netherlands, Belgium, United StatesRetrosp.No1302-
Operative outcomes

An overview of all extracted operative data can be found in Table 3.

Table 3 Operative outcomes.
Ref.Blood loss (mL)Operative time (min)Intraoperative blood transfusion (%)Conversion rate (%)Major resection proportion (%)R0 resection proportion (%)
LLR in general
Abu Hilal et al[24]300 (20-3000)220 (40-540)-8--
Abu Hilal et al[71]363 (500)1220 (145)1212-96
Allard et al[60]---1.7-85.8
Barkhatov et al[25]250 (0-4000)180 (41-488)-1.4--
Beard et al[43]-----77.4
Beppu et al[72]-282 (60-1120)8.4-690
Castaing et al[32]-278 ± 12315104387
Chen et al[74]-----93.6
Cheung et al[48]200 (10-1300)180 (58-460)0---
Cipriani et al[29]400 (10-2800)295 (10-540)-9.848.992.5
de’Angelis et al[44]200 (50-550)210.5 (60-420)5.85.8-82.7
Efanov et al[77]---3--
Fretland et al[9]300 (224 -375)2123 (108-138)2-2--
Goumard et al[45]100 (10 - 805)----81
Guerron et al[50]376 ± 122239 ± 175---
Inoue et al[80]99 ± 207204 ± 1014.34.2--
Iwahashi et al[81]198 ± 39377 ± 29----
Karagkounis et al[46]200 (50-500)1235 (185-307)14.67.7-78.5
Kasai et al[82]50 (0-500)268 ± 104--18.2-
Kazaryan et al[26]300 (< 50-> 5000)192 (64-635)164.2-93.4
Kubota et al[51]287.3 ± 459.3333.9 ± 150.32.4---
Langella et al[52]100 ± 143.7-0-5.4-
Lewin et al[84]----27-
Martínez-Cecilia et al[30]250 (10-2600)1230 (30-555)1117.62188
Nguyen et al[31]200 (20-2500)234 (60-555)103.14594.4
Nomi et al[27]200 (0-3000)245 (60-540)13.36.769.294.2
Postriganova et al[28]250 (0-4000)152 (29-488)-3.2--
Qiu et al[41]215 ± 170235 ± 70-6.7--
Ratti et al[53]250 (100-900)220 (150-540)7.715.426.9-
Robles-Campos et al[49]100 (50-300)1120 (90-180)14.2-11.595.8
Shim et al[54]100 (30-950)135 (40-360)9.1-9.1-
Tabchouri et al[70]----39-
Tohme et al[55]150 (50-150)1-12-2388
Topal et al[86]50 (10-300)1120 (80-200)1--22-
Yue et al[39]260 (180-430)180 (160-260)57.7-78
Zeng et al[56]250 (160-420)200 (150-230)----
Major LLR
Abu Hilal et al[24]875 (75-3000)330 (180-540)-1933-
Abu Hilal et al[90]700 (75-3000)300 (180-465)22-10095
Nomi et al[57]300 (10-3000)274 (100-540)10.810.810091.4
Topal et al[58]550 (100-4000)257.5 (75-360)--10095
Minor LLR
Abu Hilal et al[24]175 (20-1400)180 (40-340)-433-
Vavra et al[63]132.3 ± 218166.4 ± 81.5--0-
LLR of posterosuperior segments
Okuno et al[42]100 (10-800)217 (62-586)3.5-13.886.2
Portigliotti et al[92]195 (0-1300)195 (40-600)1.22.5--
Efanov et al[94]282 (0-3300)327 (80-755)----
Parenchyma sparing LLR
Aghayan et al[47]200 (< 50-4000)134 (20-373)-1.7-81
Montalti et al[33]250 (0-2800)276 ± 10.1-14.97-
Okumura et al[95]120 (0-2900)196 (20-480)2.43.7-96.3
Simultaneous laparoscopic colorectal and liver resection
Berti et al[40]200 (70-1000)240 (120-450)-0--
Dagher et al[61]229 ± 228332 ± 11087890
Ferretti et al[64]200 (0-1800)360 (120-690)8.54.9--
Jung et al[96]325 (50-900)290 (183-551)-0--
Ratti et al[65]350 (100-1000)420 (170-720)8424-
Shin et al[34]-336 ± 11913.82.829.4-
van der Poel et al[97]200 (100-700)1206 (166-308)1-5093
Xu et al[35]175 (100-275)246.75 ± 78.2020-20-
Two-stage hepatectomy
Okumura et al[59] FSH50 (0-350)159 (70-415)03-97
SSH225 (50-1300)305 (150-480)1311-95
Repeat LLR
Nomi et al[36]1st200 (10-3000)210 (40-540)9.94.34693.6
2nd240 (10-1100)210 (90-600)2042.697.9
3rd150 (10-600)250 (100-515)01.63095
Hallet et al[37]-252.5 (180-322.5)14.83.792.684.6
van der Poel et al[38]200 (50-600)193 (120-270)-11.152.491.8

For LLR in general, the reported median and mean blood loss volume varied between 50 mL and 400 mL. Median and mean values of operative time varied between 120 and 377 min. High variations in blood loss, ranging from almost no blood loss to 3 L or more, were reported by several authors[24-28]. As stated by Abu Hilal et al[24], major hepatectomy was frequently associated with higher blood loss, as well as increased conversion rates, operative times and length of stay. These findings are in line with other data included in the Table 3. Greater variations in blood loss (negligible to more than 2 L) were usually associated with greater variations in operative time (less than 60 min to more than 480 min)[24-31]. Correlated with an increased rate of major resection (40% or higher), greater variations were reported in blood loss, operative time[27,29,31], intraoperative transfusion rates (10%-16%)[27,31,32], as well as conversion rates (approximately 10%)[29,32].

Similar conclusions could be drawn when considering data reported about major LLRs specifically. Compared to LLR in general, major LLRs were marked by a higher median blood loss and operative time, as well as an increased variation in blood loss, operative time, intraoperative transfusion rates as well as conversion rates. These differences were even more distinct when compared to minor LLR only. We observed that variations in blood loss and operative time were also higher when considering LLR of the posterosuperior segments.

Data on parenchyma sparing LLR also illustrated a wide variation in blood loss. In the report by Montalti et al[33], besides great variation in blood loss (0-2800 mL), a rather high conversion rate of 14.9% was noted, which, according to the authors, was impacted by the amount of blood loss during LLR. Moreover, it was reported that the rate of R1 resections also correlated with the amount of blood loss. However, major LLRs were characterized by high R0 resection rates although blood loss in this specific subset seemed to be higher compared to parenchyma sparing LLR.

In simultaneous laparoscopic colorectal and liver resection, reported blood loss was low. Median and mean values ranged from 175 to 350 mL with the upper limits of variation being much lower than in major LLRs. Concerning operative times, the median and mean values ranged from 206 to 420 minutes, along with upper limits of variation that were frequently higher than in major LLRs. Both Shin et al[34] and Xu et al[35] reported higher transfusion rates (13.8% and 20%, respectively), which could again be explained by a large proportion of major hepatectomies (29.4% and 20%, respectively).

One included study provided data on TSH. Blood loss, operative times, intraoperative transfusion rates and conversion rates were higher in second stage hepatectomies (SSH) when compared to first stage hepatectomies (FSH). However, the numbers were not exceptionally high.

In repeat LLRs, blood loss and operative times did not differ from primary LLRs. Nomi et al[36] reported lower transfusion and conversion rates, while Hallet et al[37] reported higher transfusion rates and van der Poel et al[38] reported higher conversion rates compared to average primary LLRs. Again this could be due to higher major LLR proportions reported by Hallet et al[37] and van der Poel et al[38].

No striking differences were noted between data from studies that included patients with a high (> 70 years)[30,39,40] or low (< 55 years)[41,42] median age.

The R0 resection rate was found to be ≥ 90% in 20 out of 32 studies (62.5%) that reported on this topic. In only 7 studies, the R0 resection rate was lower than 85%[37,39,43-47]. Beard et al[43] stated that the lower R0 resection rate in their study could be due to the long inclusion period of 15 years. A similar argumentation was found in the reports by de'Angelis et al[44], Yue et al[39] and Aghayan et al[47], which comprised an inclusion period of 13, 17 and 19 years, respectively. Other explanations were not provided.

Postoperative short-term outcomes

All extracted postoperative short-term data are listed in Table 4.

Table 4 Postoperative short-term outcomes.
Ref.
Hospital stay (d)
Morbidity (%)
Major complications (%)
90-d mortality (%)
Time to AC (d)
LLR in general
Abu Hilal et al[24]4 (1-15)-11--
Abu Hilal et al[71]4 (2.5)1----
Allard et al[60]11.4 ± 10-17.62.3-
Beard et al[43]4 (2-6)127.814.8--
Beppu et al[72]12 (3-192)14.1-0-
Castaing et al[32]10 (5-50)27---
Cheung et al[48]4.5 (3-56)105--
Cipriani et al[29]4 (1-57)23.3-0.8-
de’Angelis et al[44]6 (2-13)17.3-0-
Efanov et al[77]-15-0-
Eveno et al[78]--17.9--
Fretland et al[12]-19---
Fretland et al[9]2.2 (1.9-2.5)219-0-
Goumard et al[45]4 (1 - 12.5)2614--
Guerron et al[50]3.7 ± 0.5150--
Inoue et al[80]10.8 ± 11.28.7---
Karagkounis et al[46]4 (3-5)126.24.6--
Kasai et al[82]4 (2-15)15---
Kazaryan et al[26]3 (1-42)----
Kubota et al[51]7.3 ± 1.82.40--
Langella et al[52]5 (3-13)13.52.7--
Martínez-Cecilia et al[30]5 (3-33)2250.4-
Nguyen et al[31]4 (17-22)12---
Nomi et al[27]-41.717.50.8-
Postriganova et al[28]3 (3-4)117.1--
Qiu et al[41]7.5 ± 1.526.2---
Ratti et al[53]3 (4-37)20.26.71-
Robles-Campos et al[49]4 (4-5)111.56.25--
Shim et al[54]8.5 (5-22)9.10--
Tabchouri et al[70]---0.4-
Tohme et al[55]4 (3-6)1266-42 (34-54)1
Topal et al[86]5 (3-7)114---
Yue et al[39]10 (7-32)276.41.3-
Zeng et al[56]10 (8-25)17.72.5--
Major LLR
Abu Hilal et al[24]5 (2-12)-19--
Abu Hilal et al[90]5 (3-20)14-0-
Nomi et al[57]10 (5-57)50.523.70-
Topal et al[58]-35-0-
Minor LLR
Abu Hilal et al[24]3 (1-15)-7--
Vavra et al[63]8.4 ± 24---
LLR of posterosuperior segments
Okuno et al[42]4 (1-12)20.710.30-
Portigliotti et al[92]-35.513.50-
Efanov et al[94]9 (4-29)--0-
Parenchyma sparing LLR
Aghayan et al[47]3 (1-35)14.5-0-
Montalti et al[33]6 ± 0.2820.2---
Okumura et al[95]6 (1-45)116.10-
Simultaneous laparoscopic colorectal and liver resection
Berti et al[40]8 (4-30)----
Dagher et al[61]10.3 ± 9.61546-
Ferretti et al[64]8 (3-84)31-2.1-
Jung et al[96]8 (5-23)1713--
Ratti et al[65]9 (4-17)24-0-
Shin et al[34]12 ± 620.2---
van der Poel et al[97]6 (5-9)1-15--
Xu et al[35]9 (8.25-11.75)15---
Two-stage hepatectomy
Okumura et al[59]6 (0-34)1680-
FSH
SSH9 (4-49)261831.4 mo (0.9-3.5 mo)
Repeat LLR
Nomi et al[36]7 (2-45)34.816.30.7-
1st
2nd7 (4-71)27.76.40-
3rd9 (4-15)30100-
Hallet et al[37]9 (8-18)1----
van der Poel et al[38]4 (3-7)-70.7-

When considering LLR in general and specific types of LLR, median and mean values of hospital stay ranged from 2.2 to 12 d.

Twenty-eight research groups reported on postoperative morbidity, out of which 25 (89%) mentioned that morbidity occurred in at least 10% of the cases. More than half of these 28 research groups (64%) reported morbidity rates of at least 15%. Sixteen research groups reported on both morbidity rates and major complication rates. These 16 reports indicated that, in many cases, approximately half of the complications were major complications[27,43,45,48,49], and otherwise, the proportion of major complications to all postoperative complications was less than half or nil[30,39,46,50-56]. Nomi et al[27] reported very high morbidity and major complication rates of 41.7% and 17.5%, respectively. Besides a long inclusion period of 13 years, no other clear explanation could be identified.

In major LLR, morbidity rates reported by Nomi et al[57] and Topal et al[58] were higher compared to LLR in general (50.5% and 35%, respectively). Overall, reported morbidity rates and major complication rates for LLR of posterosuperior segments, parenchyma sparing LLR, and simultaneous LLR were in line with those reported for LLR in general. Nomi et al[36] mentioned that second or third LLRs carry an increased risk for complications due to intra-abdominal adhesions, variations in liver anatomy in the hypertrophied liver remnant and the possibility of chemotherapy-induced liver injury. However, the authors reported similar morbidity rates for both repeat LLR and primary LLR, thereby confirming the feasibility and safety of second and third LLR. Okumura et al[59] reported similar findings in TSH, with slightly higher morbidity and major complication rates after SSH compared to FSH.

Based on the extracted data, the overall reported 90 d postoperative mortality (POM) rates were very low, even when considering specific types of LLR. The highest reported 90 d POM for LLR in general was 2.3%[60]. In studies concerning major LLR, LLR of posterosuperior segments and parenchyma sparing LLR specifically, no 90 d POM occurred. Tranchart et al[61] and Okumura et al[59] reported a slightly higher 90 d mortality rate in simultaneous laparoscopic colorectal and liver resection (6%) and after SSH (3%), respectively, without any clear explanation being provided.

The time interval between LLR and adjuvant chemotherapy (AC) was only reported by 2 research groups. For LLR in general, Tohme et al[55] reported a median interval of 42 d [interquartile range (IQR): 34-54 d]. Okumura et al[59] reported a median interval of 1.4 mo (range: 0.9-3.5 mo) after TSH.

Long-term postoperative outcomes

An overview of all extracted long-term postoperative data is demonstrated in Table 5.

Table 5 Long-term and oncologic outcomes.
Ref.
Recurrence rate (%)
1-yr OS (%)
3-yr OS (%)
5-yr OS (%)
10-yr OS (%)
1-yr DFS (%)
3-yr DFS (%)
5-yr DFS (%)
1-yr RFS (%)
3-yr RFS (%)
5-yr RFS (%)
LLR in general
Abu Hilal et al[71]16 (after median FU of 22 mo)----------
Allard et al[60]--8570--4231---
Barkhatov et al[25]---54-------
Beard et al[43]---60---44---
Beppu et al[72]-96.384.270.1----70.754.553.4
Berardi et al[73]56.9 (after median FU of 8.4 mo)947454----664637
Castaing et al[32]57 (after median FU of 30 mo)978264-704735653030
Cipriani et al[75]57.785.966.7-----54.229.4-
Cipriani et al[29]-90.876.864.3-68.544.135.860.530.423.7
D’Hondt et al[76]---65-------
de’Angelis et al[44]44.2 (after mean FU of 58.6 ± 44.4 mo)96.180.773.1-7528.821.1---
Eveno et al[78]--7170--3427---
Guerron et al[50]35 (after median FU of 16 mo)----------
Hirokawa et al[79]-1008888-614141---
Iwahashi et al[81]-1008442-571414---
Karagkounis et al[46]--7662-------
Kasai et al[82]-10085.468-55.730.430.4---
Kazaryan et al[26]-846947-634542442424
Kazaryan et al[83]---46-------
Kubota et al[51]--88.4--------
Langella et al[52]37.8 (after median FU of 35.7 ± 24.9 mo)-91.8---69.1----
Lewin et al[84]---54------36
Martínez-Cecilia et al[30]-936843----714331
Nguyen et al[31]-886950-654343---
Postriganova et al[28]-846449-614541483533
Postriganova et al[28]38.5----------
Postriganova et al[28]67.7 (after median FU of 40 mo)92.571.549.3-72.733.522.7---
Postriganova et al[28]-----68.222.718.1---
Tabchouri et al[70]72 (after median FU of 16 mo)-827143------
Tohme et al[55]--74.451.3-------
Vibert et al[87]-9787--7451----
Yue et al[39]52.5 (after FU of 31 mo)--52---45---
Yun et al[88]--95--------
Andorra et al[89]---43.5-------
Major LLR
Nomi et al[57]67.7 (after median FU of 39 mo)----------
Topal et al[58]-90-48-60-43---
Minor LLR
Vavra et al[63]---82.1---63.2---
LLR of posterosuperior segments
Montalti et al[91]-96.470.862.9----63.737.132.5
Okuno et al[42]-100------49.9--
Scuderi et al[93]---------36-
Efanov et al[94]---60-------
Parenchyma sparing LLR
Aghayan et al[47]64 (after median FU of 6 mo)-6848-----3634
Montalti et al[33]57.9 (after mean follow-up of 30.9 mo ± 1.71)987559----64.235.231
Okumura et al[95]59.8 (after median FU of 33.9 mo)-85.1------28.8-
Martínez-Cecilia et al[62]-948265----827154
Simultaneous laparoscopic colorectal and liver resection
Berti et al[40]60 (after median FU of 19 mo)----------
Dagher et al[61]28 (after median FU of 26 mo)9778--7964----
Ferretti et al[64]28.2 (after median FU of 29 mo)98.882.171.9-85.665.963---
Ratti et al[65]36 (after mean FU of 37 mo)----------
Shin et al[34]--74.4---58.5--59.6-
Xu et al[35]--51.3---31.6----
Two-stage hepatectomy
Okumura et al[59]--80--------
Repeat LLR
Nomi et al[36]77.8 (after a median FU of 43 mo)--43.2-------
Hallet et al[37]66.7 (after a median FU of 20.7 mo)---------21.4

When considering LLR in general along with the specific types of LLR, 1-year OS rates ranged from 84% to 100%, with 18 out of 21 research groups (86%) reporting 1-year OS rates of ≥ 90%. The reported 3-year and 5-year OS rates for LLR in general were marked by some variation, ranging from 64% to 95% and from 42% to 88%, respectively.

The reported DFS rates for LLR in general at 1, 3 and 5 years ranged from 55.7% to 75%, 14% to 69.1% and 14% to 45%, respectively. Remarkably, 3- and 5-year DFS rates reported by the same research groups were often the same or differed only slightly.

For LLR in general, RFS rates ranged from 44% to 71%, 24% to 54.5% and 24% to 53.4% at 1, 3 and 5 years, respectively. Again, it was observed that 3- and 5-year RFS rates reported by the same research group were equal or comparable. RFS rates for LLR of posterosuperior segments were similar to those for LLR in general. Martínez-Cecilia et al[62] reported improved RFS rates for parenchyma sparing LLR.

The reported 5-year OS and DFS rates after major LLR (48% and 43%, respectively)[58] were much lower compared to minor LLR (82.1% and 63.2%)[63], indicating worse long-term and oncologic outcome after major LLR. The 5-year DFS for minor LLR was 63.2% on the contrary, which was higher compared to LLR in general, indicating a better oncologic outcome.

In simultaneous laparoscopic colorectal and liver resection, the 1-year DFS rate was reported to be higher (79% and 85.6%) compared to LLR in general[61,64]. Accordingly, 3- and 5-year DFS rates after simultaneous LLR were also higher compared to LLR in general, which suggests that simultaneous LLR seems to provide equal or better long-term and oncologic outcomes compared to other general LLR procedures.

Long-term outcomes did not seem to be particularly compromised when reported R0 resection rates were lower[37,39,43-47].

Studies in which the median or mean FU for recurrence after LLR in general exceeded 24 mo, recurrence rates ranged from 37.8% to 67.7%. When FU was shorter, recurrence rates of 16% to 72% were also reported. Recurrence rates after major LLR and parenchyma sparing LLR were similar, ranging from 57.9% to 67.7%, regardless of the median or mean duration of FU (shorter or longer than 24 mo). Recurrence rates after simultaneous LLR seemed to be somewhat lower, with 3 research groups reporting recurrence rates of 28%, 28.2% and 36%[61,64,65], with a median and mean FU exceeding 24 mo. These findings were in line with the higher DFS rates associated with simultaneous LLR as mentioned earlier. After repeat LLR, reported recurrence rates were found to be higher, ranging from 77.8% to 66.7%[36,37].

General conclusions reported about LLR for CRLM

The reported general conclusions per included paper can be found in Table 6.

Table 6 General conclusions about laparoscopic liver resections.
Ref.SafeFeasibleEffectiveOncological efficiencyShort-term advantages
LLR in general
Abu Hilal et al[71]Yes-Yes--
Allard et al[60]---YesYes
Beppu et al[72]---YesYes
Castaing et al[32]---Yes-
Cheung et al[48]Yes-YesYesYes
Cipriani et al[75]Yes--YesYes
Cipriani et al[29]---YesYes
D’Hondt et al[76]---Yes-
de’Angelis et al[44]---YesYes
Eveno et al[78]---YesYes
Fretland et al[12]---Yes-
Guerron et al[50]---YesYes
Inoue et al[80]Yes---Yes
Iwahashi et al[81]YesYes-Yes-
Karagkounis et al[46]---YesYes
Kazaryan et al[83]Yes--Yes-
Kubota et al[51]--YesYes-
Langella et al[52]Yes--Yes-
Lewin et al[84]---Yes-
Martínez-Cecilia et al[30]---YesYes
Nguyen et al[31]YesYes-Yes-
Nomi et al[27]Yes--Yes-
Qiu et al[41]YesYes--Yes
Ratti et al[53]-YesYesYesYes
Robles-Campos et al[49]---YesYes
Tabchouri et al[70]---Yes-
Tohme et al[55]----Yes
Topal et al[86]---YesYes
Yue et al[39]---Yes-
Yun et al[88]-Yes---
Zeng et al[56]YesYes-Yes-
Major LLR
Abu Hilal et al[90]Yes-YesYes-
Nomi et al[57]Yes----
Topal et al[58]-Yes-Yes-
Minor LLR
Vavra et al[63]--YesYes-
LLR of posterosuperior segments
Okuno et al[42]----Yes
Portigliotti et al[92]----Yes
Parenchyma sparing LLR
Aghayan et al[47]Yes--Yes-
Montalti et al[33]---Yes-
Okumura et al[95]---YesYes
Simultaneous laparoscopic colorectal and liver resection
Berti et al[40]-YesYes--
Dagher et al[61]---Yes-
Ferretti et al[64]YesYes-Yes-
Jung et al[96]-Yes--Yes
Ratti et al[65]-Yes-YesYes
Shin et al[34]---YesYes
van der Poel et al[97]Yes----
Xu et al[35]YesYesYes-Yes
Two-stage hepatectomy
Okumura et al[59]YesYes-Yes-
Repeat LLR
Nomi et al[36]YesYes---
Hallet et al[37]YesYes---
van der Poel et al[38]-Yes--Yes

There was not a single paper with a negative conclusion on safety, feasibility, effectiveness or oncological efficiency of LLR for CRLM. It was striking that in 26 out of 31 (84%) papers that reported on LLR in general, it was mentioned that the oncological efficiency was certainly not compromised by this approach. Also, in studies that had discussed minor and parenchyma sparing LLR, as well as in most papers concerning major and simultaneous LLR, a similar message regarding oncological efficiency was reported. Safety, feasibility and short-term advantages of LLR for CRLM were reported for LLR in general, LLR of posterosuperior segments, parenchyma sparing, major, simultaneous, two-stage and repeat LLR. The mentioned short-term advantages often included reduced intraoperative blood loss, a lower morbidity rate, less pain, shorter hospital stay and sometimes shorter operative time.

Prognostic factors

An overview of studies that reported on prognostic factors associated with LLR along with their corresponding correlates and associations is shown in Table 7.

Table 7 Prognostic factors for survival in liver resection for colorectal liver metastases.
Ref.Prognostic factorAffected outcome + influenceHR (95%CI)P value
Langella et al[52]Postoperative complicationsWorse 3-yr OS3.804 (1.336-10.832)0.012
Multiple metastases3.421 (1.317-8.890)0.012
Nomi et al[27]Synchronous CRLMWorse OS1.482 (0.621-2.859)0.023
Positive surgical margin2.342 (1.356-2.912)0.012
Node-positive primary tumorNo difference in OS1.857 (0.712-3.459)0.382
Bilobar metastases1.398 (0.728-2.458)0.298
CRLM ≥ 5 cm6.813 (2.348-4.245)0.351
Postriganova et al[28]Resection margin width (< 1 mm, 1-< 3 mm, 3-< 10 mm and ≥ 10 mm)No difference in length of survival-0.988
No difference in DFS-0.978
No difference in RFS-0.913
Tabchouri et al[70]Node-positive primary tumorIncreased risk of recurrence1.611 (1.14-2.28)0.007
Extrahepatic disease before hepatectomy1.745 (1.24-2.45)0.001
R1 resection1.648 (1.08-2.52)0.021
Age > 70 yrWorse survival3.157 (1.10-3.10)0.021
Recurrence4.637 (1.60-6.26)0.002
Tohme et al[55]MILS (vs OLR)Timely initiation of AC2.23 (1.16-4.31)0.017
OLR with postoperative complications (vs MILS without complications)0.45 (0.23-0.86)0.017
Number of lesions (solitary vs multiple)1.71 (1.14-2.54)0.009
Length of stay (> 4 vs ≤ 4 d)0.64 (0.41-0.99)0.043
AC more than 60 d after surgeryWorse RFS0.05
Worse OS0.06
Topal et al[86]Fong’s CRSWorse DFS1.46 (1.19-1.78)0.0002
Preoperative systemic chemotherapy1.70 (1.15-2.52)0.008
Male sexWorse OS2.54 (1.45-4.45)0.001
Interval systemic chemotherapy and surgery for CRLM1.06 (1.01-1.10)0.012
Fong’s CRS1.49 (1.16-1.91)0.002
Yue et al[39]TNM stage of primary tumor (III vs I-II)Worse OS1.981 (1.258-3.854)0.021
Disease-free interval (< 12 vs ≥ 12 mo)1.610 (1.378-2.873)0.015
Number of metastases (≥3 vs < 3)1.500 (1.258-1.870)0.041
Disease-free interval (< 12 vs ≥ 12 mo)Worse DFS1.874 (1.215-2.001)0.036
Preoperative CEA levels (≥ 5 vs < 5 ng/mL)1.740 (1.418-2.108)0.028
Zeng et al[56]Disease-free interval (< 36 vs ≥ 36 mo)5-yr OS2.9871 (2.012-6.980)0.009
Disease-free interval (< 36 vs ≥ 36 mo)5-yr DFS2.9501 (1.895-3.562)0.010
Montalti et al[33]Lesions located in posterosuperior segmentsWorse tumor recurrence2.4 (1.24-4.61)0.009
Blood loss (≥ 1000 mL vs < 1000 mL)3.2 (1.23-7.99)0.012
R1 marginsNo difference in OS1.06 (0.57-3.80)0.37
CEA levels (≥ 10 µg/L vs < 10 µg/L)Worse OS4.2 (2.02-16.9)0.001
Multiple lesions (>2 vs ≤2 lesions)Increased risk of R1 margins9.32 (1.14-32.5)0.037
Cervantes et al[98]CRLM minimum size <9 mmWorse RFS1.6 (1.1-2.4)< 0.05
Worse hepatic RFS1.8 (1.2-3.0)< 0.05
De Haas et al[99]Development of adrenal metastases after LRWorse survival-0.020
Jones et al[100]SUVmean during PET-CTInsignificant negative effect on OS1.053 (0.839-1.321)0.659
Log(volume of tumor)Insignificant negative effect on OS1.699 (0.964-2.993)0.067
Ratti et al[101]Right colonic neoplasmsWorse RFS2.382 (1.46-2.75)0.042
T-stage of primary tumor (T3-T4)1.962 (1.55-3.01)0.044
RAS mutation2.122 (1.33-2.96)0.039
CRS > 32.572 (1.68-3.65)0.029
Absence of perioperative chemotherapy2.312 (1.39-3.21)0.039
Right colonic neoplasmsWorse OS2.412 (1.39-2.81)0.046
T-stage of primary tumor (T3-T4)1.862 (1.43-2.78)0.048
RAS mutation2.222 (1.42-3.07)0.037
CRS > 32.752 (1.83-3.62)0.032
Absence of perioperative chemotherapy2.162 (1.40-3.06)0.042
Nierop et al[102]Non-dHGPHigher risk of positive resection margins1.7871 (1.112-2.871)0.016
Number of CRLM1.1531 (1.077-1.234)< 0.001
Non-dHGPWorse OS1.57 (1.26-1.95)< 0.001
Positive resection margins1.41(1.13-1.76)0.002
Age at resection1.016 (1.008-1.023)< 0.001
Node positive primary1.455 (1.226-1.728)< 0.001
Number of CRLM1.078 (1.039-1.118)< 0.001
Size of CRLM1.063 (1.035-1.091)< 0.001
Preoperative CEANo difference in OS1.000 (1.000-1.000)0.898

Fourteen papers were identified which studied prognostic factors specific to LR for CRLM, including 7 (50%) exclusively for LLR for CRLM. Papers that focused on LLR specifically identified the following prognostic factors that were associated with a worse OS: Synchronous CRLM, positive surgical margins, age > 70 years, disease recurrence, a disease-free interval < 12 mo, resection of ≥ 3 metastases, carcinoembryonic antigen (CEA) levels > 10 µg/L, right colonic neoplasms, T-stage of the primary CRC ≥ T3, RAS mutation, clinical risk score, and/or absence of perioperative chemotherapy. Node-positive primary CRC, extrahepatic disease, R1 resection, a disease-free interval < 12 mo, CEA levels > 5 µg/L, lesions located in the posterosuperior segments, blood loss > 1000 mL, a CRLM minimum size < 9 mm, right colonic neoplasms, T-stage of the primary CRC ≥ T3 or T4, RAS mutation, clinical risk score and/or absence of perioperative chemotherapy were associated with worse recurrence, DFS or RFS.

DISCUSSION

Previously published systematic reviews and meta-analyses concerning LLR, have frequently discussed a set of heterogeneous groups, that besides CRLM often contain lesions from another histopathological origin, such as hepatocellular carcinoma, non-colorectal liver metastases and other malignancies[66]. Furthermore, no systematic review or meta-analysis has focused so far on potential prognostic factors of survival after LLR for CRLM specifically. In light of these facts, our aim was to provide a systematic review that specifically addressed the role of LLR for CRLM along with all relevant outcomes and prognostic factors associated. We therefore reviewed as much of the existing evidence concerning the subject to date with as few limitations as possible to make the overview as comprehensive as possible.

In 2015, Tian et al[8] published a meta-analysis comparing LLR vs OLR for CRLM. Since the majority of the articles included for the quantitative analysis of the meta-analysis were also included in the current systematic review, it is no surprise that our results are in line with those reported by Tian et al[8]. In their meta-analysis, it was found that the results of blood loss, perioperative blood transfusion, postoperative morbidity and mortality, hospitalization time, recurrence, DFS, and OS were in favor of LLR. LLR was, however, not associated with any statistical benefit regarding R0 surgical margins or operative time. In 2012, a meta-analysis on survival and prognostic factors associated with LR in metastatic CRC was published by Kanas et al[67]. Node positive primary CRC, CEA level, extrahepatic disease, poor tumor grade, positive surgical margins, multiple CRLM, and tumor diameter > 3 cm were identified as prognostic factors for survival, all with a modest, but significant, predictive relationship. Again, these findings are in line with the reported outcomes included in this systematic review.

A major variability of morbidity rates was observed in function of the research papers included in this study. Morbidity following LLR for CRLM is certainly still present and still needs attention. However, major complication rates are low.

Together with the implementation of LLR for CRLM in the early 2000s, concerns arose about the safety a feasibility of this technique to obtain rates of R0 resection margins and subsequent oncological efficiency similar to those reported after OLR for CRLM. The results of this systematic review appear to refute these concerns, since the vast majority of research groups provide a high rate of R0 resection and oncological efficiency in their reports.

Although no clear correlation between the year of publication and study outcome could be noted, some reported results seem to be influenced by long inclusion periods during which data were collected.

The optimal time interval between LR and AC is defined as 8 wk or less[55,68,69]. Since the reported median intervals were 42 d (IQR: 34-54 d) and 1.4 mo (range: 0.9-3.5 mo), LLR seems to provide the ability to initiate AC within a time frame that results in an optimal treatment sequence.

Concerning oncologic outcomes, the reported 1-, 3- and 5-year OS and DFS rates are comparable to those achieved in a recent RCT by Robles-Campos et al[49], indicating that LLR for CRLM offers adequate oncological efficiency in most centers today. As reported by Tabchouri et al[70] in 2018, among others, the risk for disease recurrence after LLR for CRLM is high. As illustrated by their results, the probability of recurrence is highest within 24 mo after the initial hepatectomy and diminishes after this point in time. This could underlie the fact that 3-year DFS and RFS rates remain stable with comparable corresponding 5-year DFS and RFS rates.

Some limitations of this systematic review should be taken into account. First, research papers often included several types of LLR besides pure LLR, such as hand-assisted and robotic LLR. Second, the studies included were performed in both high- and low-volume centers. Third, the definitions of postoperative outcomes were not uniform among the included research papers. Fourth, the definition of hospital stay differed among the included papers, with some research groups speaking of an entire hospital stay and others speaking of a postoperative hospital stay. Last, several research groups did not report on the applied definition of major postoperative complications; however, a Clavien-Dindo grade ≥ 3 was most commonly reported.

This review emphasizes the absolute need for future prospective multicenter RCTs. Robust evidence of the short- and long-term benefits of LLR is needed in order to support the increased use of LLR for CRLM compared to OLR reported by many centers.

CONCLUSION

LLR is defined as a safe and feasible surgical technique in the treatment of CRLM and associated with satisfactory oncological efficiency. Many research groups report short-term advantages compared to OLR, including reduced intraoperative blood loss, a lower morbidity rate, less pain, shorter hospital stay, and a shorter operative time in selected reports. These conclusions are not compromised when taking into account different subtypes of LLR for CRLM, such as major LLR, simultaneous LLR, LLR for posterosuperior segments, TSH, and repeat LLR. Since few reports so far have studied potential prognostic factors affecting long-term outcomes after LLR for CRLM, future research concerning this topic is needed.

ARTICLE HIGHLIGHTS
Research background

Laparoscopic liver resection (LLR) for colorectal liver metastases (CRLM) has become the gold standard in specialized centers and for well-selected patients and procedures.

Research motivation

Little is known concerning patient-related and peri-operative factors that could play a role in survival outcomes associated with LLR for CRLM.

Research objectives

The main objective was to provide an extensive summary of reported outcomes and prognostic factors associated with LLR for CRLM.

Research methods

A systematic review was performed in PubMed, EMBASE, Web of Science and the Cochrane Library, after which thorough screening was performed and data was extracted for qualitative analysis.

Research results

Qualitative analysis of 77 full-text publications shows that LLR for CRLM is safe, feasible and provides oncological efficiency. This is true for more complex laparoscopic procedures as well. Results on prognostic factors affecting long-term outcomes for LLR for CRLM are scarce.

Research conclusions

Besides short-term benefits, satisfactory oncological efficiency is reported for LLR for CRLM.

Research perspectives

Little is still known about prognostic factors affecting long-term outcomes of LLR for CRLM, and future prospective multicenter randomized controlled trials are needed to provide robust evidence.

Footnotes

Manuscript source: Invited manuscript

Specialty type: Surgery

Country/Territory of origin: Belgium

Peer-review report’s scientific quality classification

Grade A (Excellent): 0

Grade B (Very good): B

Grade C (Good): 0

Grade D (Fair): 0

Grade E (Poor): 0

P-Reviewer: Aseni P S-Editor: Ma YJ L-Editor: Filipodia P-Editor: Li JH

References
1.  Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66:683-691.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 3058]  [Cited by in F6Publishing: 2852]  [Article Influence: 407.4]  [Reference Citation Analysis (1)]
2.  Valderrama-Treviño AI, Barrera-Mera B, Ceballos-Villalva JC, Montalvo-Javé EE. Hepatic Metastasis from Colorectal Cancer. Euroasian J Hepatogastroenterol. 2017;7:166-175.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 92]  [Cited by in F6Publishing: 128]  [Article Influence: 18.3]  [Reference Citation Analysis (0)]
3.  Lazorthes F, Navarro F, Ychou M, Delpero JR, Rougier P;  ANAES. [Therapeutic management of hepatic metastases from colorectal cancers]. Gastroenterol Clin Biol. 2003;27 Spec No 2:B7.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 59]  [Cited by in F6Publishing: 62]  [Article Influence: 3.3]  [Reference Citation Analysis (0)]
4.  Rothbarth J, van de Velde CJ. Treatment of liver metastases of colorectal cancer. Ann Oncol. 2005;16 Suppl 2:ii144-ii149.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 35]  [Cited by in F6Publishing: 46]  [Article Influence: 2.4]  [Reference Citation Analysis (0)]
5.  Qin X, Xu J, Zhong Y.   Multidisciplinary management of liver metastases in colorectal cancer: Early diagnosis and treatment. Springer Netherlands; 2016.  [PubMed]  [DOI]  [Cited in This Article: ]
6.  Di Fabio F, Whistance R, Rahman S, Primrose JN, Pearce NW, Abu Hilal M. Exploring the role of laparoscopic surgery in two-stage hepatectomy for bilobar colorectal liver metastases. J Laparoendosc Adv Surg Tech A. 2012;22:647-650.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 18]  [Cited by in F6Publishing: 21]  [Article Influence: 1.8]  [Reference Citation Analysis (0)]
7.  Kilburn DJ, Chiow AK, Lewin J, Kienzle N, Cavallucci DJ, Bryant R, O'Rourke N. Laparoscopic approach to a planned two-stage hepatectomy for bilobar colorectal liver metastases. ANZ J Surg. 2016;86:811-815.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 9]  [Cited by in F6Publishing: 10]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
8.  Tian ZQ, Su XF, Lin ZY, Wu MC, Wei LX, He J. Meta-analysis of laparoscopic vs open liver resection for colorectal liver metastases. Oncotarget. 2016;7:84544-84555.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 16]  [Cited by in F6Publishing: 25]  [Article Influence: 4.2]  [Reference Citation Analysis (0)]
9.  Fretland ÅA, Dagenborg VJ, Bjørnelv GMW, Kazaryan AM, Kristiansen R, Fagerland MW, Hausken J, Tønnessen TI, Abildgaard A, Barkhatov L, Yaqub S, Røsok BI, Bjørnbeth BA, Andersen MH, Flatmark K, Aas E, Edwin B. Laparoscopic Versus Open Resection for Colorectal Liver Metastases: The OSLO-COMET Randomized Controlled Trial. Ann Surg. 2018;267:199-207.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 335]  [Cited by in F6Publishing: 408]  [Article Influence: 81.6]  [Reference Citation Analysis (0)]
10.  Yoshida H, Taniai N, Yoshioka M, Hirakata A, Kawano Y, Shimizu T, Ueda J, Takata H, Nakamura Y, Mamada Y. Current Status of Laparoscopic Hepatectomy. J Nippon Med Sch. 2019;86:201-206.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 24]  [Cited by in F6Publishing: 31]  [Article Influence: 6.2]  [Reference Citation Analysis (0)]
11.  Zhang XL, Liu RF, Zhang D, Zhang YS, Wang T. Laparoscopic vs open liver resection for colorectal liver metastases: A systematic review and meta-analysis of studies with propensity score-based analysis. Int J Surg. 2017;44:191-203.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 39]  [Cited by in F6Publishing: 34]  [Article Influence: 4.9]  [Reference Citation Analysis (0)]
12.  Fretland AA, Aghayan D, Edwin B. Long-term survival after laparoscopic vs open resection for colorectal liver metastases. J Clin Oncol. 2019;37:LBA3516.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 10]  [Cited by in F6Publishing: 11]  [Article Influence: 2.2]  [Reference Citation Analysis (0)]
13.  Syn NL, Kabir T, Koh YX, Tan HL, Wang LZ, Chin BZ, Wee I, Teo JY, Tai BC, Goh BKP. Survival Advantage of Laparoscopic Versus Open Resection For Colorectal Liver Metastases: A Meta-analysis of Individual Patient Data From Randomized Trials and Propensity-score Matched Studies. Ann Surg. 2020;272:253-265.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 86]  [Cited by in F6Publishing: 79]  [Article Influence: 19.8]  [Reference Citation Analysis (0)]
14.  Luo LX, Yu ZY, Bai YN. Laparoscopic hepatectomy for liver metastases from colorectal cancer: a meta-analysis. J Laparoendosc Adv Surg Tech A. 2014;24:213-222.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 34]  [Cited by in F6Publishing: 27]  [Article Influence: 2.7]  [Reference Citation Analysis (0)]
15.  Kalil JA, Poirier J, Becker B, Van Dam R, Keutgen X, Schadde E. Laparoscopic Parenchymal-Sparing Hepatectomy: the New Maximally Minimal Invasive Surgery of the Liver-a Systematic Review and Meta-Analysis. J Gastrointest Surg. 2019;23:860-869.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 12]  [Cited by in F6Publishing: 12]  [Article Influence: 2.4]  [Reference Citation Analysis (0)]
16.  Ciria R, Ocaña S, Gomez-Luque I, Cipriani F, Halls M, Fretland ÅA, Okuda Y, Aroori S, Briceño J, Aldrighetti L, Edwin B, Hilal MA. A systematic review and meta-analysis comparing the short- and long-term outcomes for laparoscopic and open liver resections for liver metastases from colorectal cancer. Surg Endosc. 2020;34:349-360.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 27]  [Cited by in F6Publishing: 37]  [Article Influence: 7.4]  [Reference Citation Analysis (0)]
17.  Wei M, He Y, Wang J, Chen N, Zhou Z, Wang Z. Laparoscopic vs open hepatectomy with or without synchronous colectomy for colorectal liver metastasis: a meta-analysis. PLoS One. 2014;9:e87461.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 39]  [Cited by in F6Publishing: 35]  [Article Influence: 3.5]  [Reference Citation Analysis (0)]
18.  Kasai M, Cipriani F, Gayet B, Aldrighetti L, Ratti F, Sarmiento JM, Scatton O, Kim KH, Dagher I, Topal B, Primrose J, Nomi T, Fuks D, Abu Hilal M. Laparoscopic vs open major hepatectomy: a systematic review and meta-analysis of individual patient data. Surgery. 2018;163:985-995.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 107]  [Cited by in F6Publishing: 92]  [Article Influence: 15.3]  [Reference Citation Analysis (0)]
19.  Zhou Y, Xiao Y, Wu L, Li B, Li H. Laparoscopic liver resection as a safe and efficacious alternative to open resection for colorectal liver metastasis: a meta-analysis. BMC Surg. 2013;13:44.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 44]  [Cited by in F6Publishing: 50]  [Article Influence: 4.5]  [Reference Citation Analysis (0)]
20.  Moher D, Liberati A, Tetzlaff J, Altman DG;  PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 47017]  [Cited by in F6Publishing: 43014]  [Article Influence: 2867.6]  [Reference Citation Analysis (0)]
21.  Cheng Y, Zhang L, Li H, Wang L, Huang Y, Wu L, Zhang Y. Laparoscopic vs open liver resection for colorectal liver metastases: a systematic review. J Surg Res. 2017;220:234-246.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 22]  [Cited by in F6Publishing: 22]  [Article Influence: 3.1]  [Reference Citation Analysis (0)]
22.  Moris D, Tsilimigras DI, Machairas N, Merath K, Cerullo M, Hasemaki N, Prodromidou A, Cloyd JM, Pawlik TM. Laparoscopic synchronous resection of colorectal cancer and liver metastases: A systematic review. J Surg Oncol. 2019;119:30-39.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 26]  [Cited by in F6Publishing: 31]  [Article Influence: 5.2]  [Reference Citation Analysis (0)]
23.  Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5:210.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 5711]  [Cited by in F6Publishing: 7487]  [Article Influence: 935.9]  [Reference Citation Analysis (0)]
24.  Abu Hilal M, Di Fabio F, Abu Salameh M, Pearce NW. Oncological efficiency analysis of laparoscopic liver resection for primary and metastatic cancer: a single-center UK experience. Arch Surg. 2012;147:42-48.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 76]  [Cited by in F6Publishing: 81]  [Article Influence: 6.8]  [Reference Citation Analysis (0)]
25.  Barkhatov L, Fretland ÅA, Kazaryan AM, Røsok BI, Brudvik KW, Waage A, Bjørnbeth BA, Sahakyan MA, Edwin B. Validation of clinical risk scores for laparoscopic liver resections of colorectal liver metastases: A 10-year observed follow-up study. J Surg Oncol. 2016;114:757-763.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 7]  [Cited by in F6Publishing: 8]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
26.  Kazaryan AM, Marangos IP, Røsok BI, Rosseland AR, Villanger O, Fosse E, Mathisen O, Edwin B. Laparoscopic resection of colorectal liver metastases: surgical and long-term oncologic outcome. Ann Surg. 2010;252:1005-1012.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 99]  [Cited by in F6Publishing: 104]  [Article Influence: 7.4]  [Reference Citation Analysis (0)]
27.  Nomi T, Fuks D, Louvet C, Nakajima Y, Gayet B. Outcomes of Laparoscopic Liver Resection for Patients with Large Colorectal Liver Metastases: A Case-Matched Analysis. World J Surg. 2016;40:1702-1708.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 14]  [Cited by in F6Publishing: 15]  [Article Influence: 2.1]  [Reference Citation Analysis (0)]
28.  Postriganova N, Kazaryan AM, Røsok BI, Fretland Å, Barkhatov L, Edwin B. Margin status after laparoscopic resection of colorectal liver metastases: does a narrow resection margin have an influence on survival and local recurrence? HPB (Oxford). 2014;16:822-829.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 34]  [Cited by in F6Publishing: 35]  [Article Influence: 3.5]  [Reference Citation Analysis (0)]
29.  Cipriani F, Rawashdeh M, Stanton L, Armstrong T, Takhar A, Pearce NW, Primrose J, Abu Hilal M. Propensity score-based analysis of outcomes of laparoscopic vs open liver resection for colorectal metastases. Br J Surg. 2016;103:1504-1512.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 98]  [Cited by in F6Publishing: 89]  [Article Influence: 11.1]  [Reference Citation Analysis (0)]
30.  Martínez-Cecilia D, Cipriani F, Shelat V, Ratti F, Tranchart H, Barkhatov L, Tomassini F, Montalti R, Halls M, Troisi RI, Dagher I, Aldrighetti L, Edwin B, Abu Hilal M. Laparoscopic Versus Open Liver Resection for Colorectal Metastases in Elderly and Octogenarian Patients: A Multicenter Propensity Score Based Analysis of Short- and Long-term Outcomes. Ann Surg. 2017;265:1192-1200.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 101]  [Cited by in F6Publishing: 95]  [Article Influence: 13.6]  [Reference Citation Analysis (0)]
31.  Nguyen KT, Laurent A, Dagher I, Geller DA, Steel J, Thomas MT, Marvin M, Ravindra KV, Mejia A, Lainas P, Franco D, Cherqui D, Buell JF, Gamblin TC. Minimally invasive liver resection for metastatic colorectal cancer: a multi-institutional, international report of safety, feasibility, and early outcomes. Ann Surg. 2009;250:842-848.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 206]  [Cited by in F6Publishing: 217]  [Article Influence: 14.5]  [Reference Citation Analysis (0)]
32.  Castaing D, Vibert E, Ricca L, Azoulay D, Adam R, Gayet B. Oncologic results of laparoscopic vs open hepatectomy for colorectal liver metastases in two specialized centers. Ann Surg. 2009;250:849-855.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 215]  [Cited by in F6Publishing: 232]  [Article Influence: 15.5]  [Reference Citation Analysis (0)]
33.  Montalti R, Tomassini F, Laurent S, Smeets P, De Man M, Geboes K, Libbrecht LJ, Troisi RI. Impact of surgical margins on overall and recurrence-free survival in parenchymal-sparing laparoscopic liver resections of colorectal metastases. Surg Endosc. 2015;29:2736-2747.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 38]  [Cited by in F6Publishing: 43]  [Article Influence: 4.3]  [Reference Citation Analysis (0)]
34.  Shin JK, Kim HC, Lee WY, Yun SH, Cho YB, Huh JW, Park YA, Heo JS, Kim JM. Comparative study of laparoscopic vs open technique for simultaneous resection of colorectal cancer and liver metastases with propensity score analysis. Surg Endosc. 2020;34:4772-4780.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 14]  [Cited by in F6Publishing: 16]  [Article Influence: 3.2]  [Reference Citation Analysis (0)]
35.  Xu X, Guo Y, Chen G, Li C, Wang H, Dong G. Laparoscopic resections of colorectal cancer and synchronous liver metastases: a case controlled study. Minim Invasive Ther Allied Technol. 2018;27:209-216.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 11]  [Cited by in F6Publishing: 12]  [Article Influence: 1.7]  [Reference Citation Analysis (0)]
36.  Nomi T, Fuks D, Ogiso S, Nakajima Y, Louvet C, Gayet B. Second and Third Laparoscopic Liver Resection for Patients With Recurrent Colorectal Liver Metastases. Ann Surg. 2016;263:e68-e72.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 18]  [Cited by in F6Publishing: 22]  [Article Influence: 2.8]  [Reference Citation Analysis (0)]
37.  Hallet J, Sa Cunha A, Cherqui D, Gayet B, Goéré D, Bachellier P, Laurent A, Fuks D, Navarro F, Pessaux P;  French Colorectal Liver Metastases Working Group;  Association Française de Chirurgie. Laparoscopic Compared to Open Repeat Hepatectomy for Colorectal Liver Metastases: a Multi-institutional Propensity-Matched Analysis of Short- and Long-Term Outcomes. World J Surg. 2017;41:3189-3198.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 31]  [Cited by in F6Publishing: 39]  [Article Influence: 5.6]  [Reference Citation Analysis (0)]
38.  van der Poel MJ, Barkhatov L, Fuks D, Berardi G, Cipriani F, Aljaiuossi A, Lainas P, Dagher I, D'Hondt M, Rotellar F, Besselink MG, Aldrighetti L, Troisi RI, Gayet B, Edwin B, Abu Hilal M. Multicentre propensity score-matched study of laparoscopic vs open repeat liver resection for colorectal liver metastases. Br J Surg. 2019;106:783-789.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 43]  [Cited by in F6Publishing: 52]  [Article Influence: 10.4]  [Reference Citation Analysis (0)]
39.  Yue M, Li S, Yan G, Li C, Kang Z. Short- and long-term outcomes of laparoscopic hepatectomy for colorectal liver metastases in elderly patients. Cancer Manag Res. 2018;10:2581-2587.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 7]  [Cited by in F6Publishing: 7]  [Article Influence: 1.2]  [Reference Citation Analysis (0)]
40.  Berti S, Francone E, Minuto M, Bonfante P, Sagnelli C, Bianchi C, Tognoni A, Falco E. Synchronous totally laparoscopic management of colorectal cancer and resectable liver metastases: a single center experience. Langenbecks Arch Surg. 2015;400:495-503.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 18]  [Cited by in F6Publishing: 17]  [Article Influence: 1.9]  [Reference Citation Analysis (0)]
41.  Qiu J, Chen S, Pankaj P, Wu H. Laparoscopic hepatectomy for hepatic colorectal metastases -- a retrospective comparative cohort analysis and literature review. PLoS One. 2013;8:e60153.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 24]  [Cited by in F6Publishing: 27]  [Article Influence: 2.5]  [Reference Citation Analysis (0)]
42.  Okuno M, Goumard C, Mizuno T, Omichi K, Tzeng CD, Chun YS, Aloia TA, Fleming JB, Lee JE, Vauthey JN, Conrad C. Operative and short-term oncologic outcomes of laparoscopic vs open liver resection for colorectal liver metastases located in the posterosuperior liver: a propensity score matching analysis. Surg Endosc. 2018;32:1776-1786.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 34]  [Cited by in F6Publishing: 40]  [Article Influence: 5.7]  [Reference Citation Analysis (0)]
43.  Beard RE, Khan S, Troisi RI, Montalti R, Vanlander A, Fong Y, Kingham TP, Boerner T, Berber E, Kahramangil B, Buell JF, Martinie JB, Vrochides D, Shen C, Molinari M, Geller DA, Tsung A. Long-Term and Oncologic Outcomes of Robotic Versus Laparoscopic Liver Resection for Metastatic Colorectal Cancer: A Multicenter, Propensity Score Matching Analysis. World J Surg. 2020;44:887-895.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 31]  [Cited by in F6Publishing: 22]  [Article Influence: 5.5]  [Reference Citation Analysis (0)]
44.  de'Angelis N, Eshkenazy R, Brunetti F, Valente R, Costa M, Disabato M, Salloum C, Compagnon P, Laurent A, Azoulay D. Laparoscopic vs open resection for colorectal liver metastases: a single-center study with propensity score analysis. J Laparoendosc Adv Surg Tech A. 2015;25:12-20.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 37]  [Cited by in F6Publishing: 40]  [Article Influence: 4.4]  [Reference Citation Analysis (0)]
45.  Goumard C, Nancy You Y, Okuno M, Kutlu O, Chen HC, Simoneau E, Vega EA, Chun YS, David Tzeng C, Eng C, Vauthey JN, Conrad C. Minimally invasive management of the entire treatment sequence in patients with stage IV colorectal cancer: a propensity-score weighting analysis. HPB (Oxford). 2018;20:1150-1156.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 6]  [Cited by in F6Publishing: 6]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
46.  Karagkounis G, Akyuz M, Guerron AD, Yazici P, Aucejo FN, Quintini C, Miller CM, Vogt DP, Fung JJ, Berber E. Perioperative and oncologic outcomes of minimally invasive liver resection for colorectal metastases: A case-control study of 130 patients. Surgery. 2016;160:1097-1103.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 12]  [Cited by in F6Publishing: 12]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
47.  Aghayan DL, Pelanis E, Avdem Fretland Å, Kazaryan AM, Sahakyan MA, Røsok BI, Barkhatov L, Bjørnbeth BA, Jakob Elle O, Edwin B. Laparoscopic Parenchyma-sparing Liver Resection for Colorectal Metastases. Radiol Oncol. 2018;52:36-41.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 18]  [Cited by in F6Publishing: 22]  [Article Influence: 3.1]  [Reference Citation Analysis (0)]
48.  Cheung TT, Poon RT, Yuen WK, Chok KS, Tsang SH, Yau T, Chan SC, Lo CM. Outcome of laparoscopic vs open hepatectomy for colorectal liver metastases. ANZ J Surg. 2013;83:847-852.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 42]  [Cited by in F6Publishing: 47]  [Article Influence: 4.3]  [Reference Citation Analysis (0)]
49.  Robles-Campos R, Lopez-Lopez V, Brusadin R, Lopez-Conesa A, Gil-Vazquez PJ, Navarro-Barrios Á, Parrilla P. Open vs minimally invasive liver surgery for colorectal liver metastases (LapOpHuva): a prospective randomized controlled trial. Surg Endosc. 2019;33:3926-3936.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 49]  [Cited by in F6Publishing: 75]  [Article Influence: 15.0]  [Reference Citation Analysis (0)]
50.  Guerron AD, Aliyev S, Agcaoglu O, Aksoy E, Taskin HE, Aucejo F, Miller C, Fung J, Berber E. Laparoscopic vs open resection of colorectal liver metastasis. Surg Endosc. 2013;27:1138-1143.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 57]  [Cited by in F6Publishing: 54]  [Article Influence: 4.5]  [Reference Citation Analysis (0)]
51.  Kubota Y, Otsuka Y, Tsuchiya M, Katagiri T, Ishii J, Maeda T, Tamura A, Kaneko H. Efficacy of laparoscopic liver resection in colorectal liver metastases and the influence of preoperative chemotherapy. World J Surg Oncol. 2014;12:351.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 16]  [Cited by in F6Publishing: 16]  [Article Influence: 1.6]  [Reference Citation Analysis (0)]
52.  Langella S, Russolillo N, D'Eletto M, Forchino F, Lo Tesoriere R, Ferrero A. Oncological safety of ultrasound-guided laparoscopic liver resection for colorectal metastases: a case-control study. Updates Surg. 2015;67:147-155.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 19]  [Cited by in F6Publishing: 21]  [Article Influence: 2.3]  [Reference Citation Analysis (0)]
53.  Ratti F, Fiorentini G, Cipriani F, Catena M, Paganelli M, Aldrighetti L. Laparoscopic vs Open Surgery for Colorectal Liver Metastases. JAMA Surg. 2018;153:1028-1035.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 55]  [Cited by in F6Publishing: 57]  [Article Influence: 9.5]  [Reference Citation Analysis (0)]
54.  Shim JR, Lee SD, Park HM, Lee EC, Park B, Han SS, Kim SH, Park SJ. Outcomes of liver resection in patients with colorectal liver metastases by laparoscopic or open surgery. Ann Hepatobiliary Pancreat Surg. 2018;22:223-230.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 5]  [Cited by in F6Publishing: 5]  [Article Influence: 0.8]  [Reference Citation Analysis (0)]
55.  Tohme S, Goswami J, Han K, Chidi AP, Geller DA, Reddy S, Gleisner A, Tsung A. Minimally Invasive Resection of Colorectal Cancer Liver Metastases Leads to an Earlier Initiation of Chemotherapy Compared to Open Surgery. J Gastrointest Surg. 2015;19:2199-2206.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 44]  [Cited by in F6Publishing: 48]  [Article Influence: 5.3]  [Reference Citation Analysis (0)]
56.  Zeng Y, Tian M. Laparoscopic vs open hepatectomy for elderly patients with liver metastases from colorectal cancer. J BUON. 2016;21:1146-1152.  [PubMed]  [DOI]  [Cited in This Article: ]
57.  Nomi T, Fuks D, Kawaguchi Y, Mal F, Nakajima Y, Gayet B. Laparoscopic major hepatectomy for colorectal liver metastases in elderly patients: a single-center, case-matched study. Surg Endosc. 2015;29:1368-1375.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 45]  [Cited by in F6Publishing: 47]  [Article Influence: 4.7]  [Reference Citation Analysis (0)]
58.  Topal H, Tiek J, Aerts R, Topal B. Outcome of laparoscopic major liver resection for colorectal metastases. Surg Endosc. 2012;26:2451-2455.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 50]  [Cited by in F6Publishing: 41]  [Article Influence: 3.4]  [Reference Citation Analysis (0)]
59.  Okumura S, Goumard C, Gayet B, Fuks D, Scatton O. Laparoscopic vs open two-stage hepatectomy for bilobar colorectal liver metastases: A bi-institutional, propensity score-matched study. Surgery. 2019;166:959-966.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 14]  [Cited by in F6Publishing: 18]  [Article Influence: 3.6]  [Reference Citation Analysis (0)]
60.  Allard MA, Cunha AS, Gayet B, Adam R, Goere D, Bachellier P, Azoulay D, Ayav A, Navarro F, Pessaux P;  Colorectal Liver Metastases-French Study Group. Early and Long-term Oncological Outcomes After Laparoscopic Resection for Colorectal Liver Metastases: A Propensity Score-based Analysis. Ann Surg. 2015;262:794-802.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 73]  [Cited by in F6Publishing: 82]  [Article Influence: 10.3]  [Reference Citation Analysis (0)]
61.  Tranchart H, Fuks D, Vigano L, Ferretti S, Paye F, Wakabayashi G, Ferrero A, Gayet B, Dagher I. Laparoscopic simultaneous resection of colorectal primary tumor and liver metastases: a propensity score matching analysis. Surg Endosc. 2016;30:1853-1862.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 2]  [Cited by in F6Publishing: 2]  [Article Influence: 0.2]  [Reference Citation Analysis (0)]
62.  Martínez-Cecilia D, Fontana M, Siddiqi NN, Halls M, Barbaro S, Abu-Hilal M. Laparoscopic parenchymal sparing resections in segment 8: techniques for a demanding and infrequent procedure. Surg Endosc. 2018;32:2012-2019.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 17]  [Cited by in F6Publishing: 13]  [Article Influence: 1.9]  [Reference Citation Analysis (0)]
63.  Vavra P, Nowakova J, Ostruszka P, Hasal M, Jurcikova J, Martinek L, Penhaker M, Ihnat P, Habib N, Zonca P. Colorectal cancer liver metastases: laparoscopic and open radiofrequency-assisted surgery. Wideochir Inne Tech Maloinwazyjne. 2015;10:205-212.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 5]  [Cited by in F6Publishing: 9]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
64.  Ferretti S, Tranchart H, Buell JF, Eretta C, Patriti A, Spampinato MG, Huh JW, Vigano L, Han HS, Ettorre GM, Jovine E, Gamblin TC, Belli G, Wakabayashi G, Gayet B, Dagher I. Laparoscopic Simultaneous Resection of Colorectal Primary Tumor and Liver Metastases: Results of a Multicenter International Study. World J Surg. 2015;39:2052-2060.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 33]  [Cited by in F6Publishing: 38]  [Article Influence: 4.2]  [Reference Citation Analysis (0)]
65.  Ratti F, Catena M, Di Palo S, Staudacher C, Aldrighetti L. Impact of totally laparoscopic combined management of colorectal cancer with synchronous hepatic metastases on severity of complications: a propensity-score-based analysis. Surg Endosc. 2016;30:4934-4945.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 34]  [Cited by in F6Publishing: 37]  [Article Influence: 4.6]  [Reference Citation Analysis (0)]
66.  Tranchart H, Dagher I. Laparoscopic liver resection: a review. J Visc Surg. 2014;151:107-115.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 31]  [Cited by in F6Publishing: 34]  [Article Influence: 3.1]  [Reference Citation Analysis (0)]
67.  Kanas GP, Taylor A, Primrose JN, Langeberg WJ, Kelsh MA, Mowat FS, Alexander DD, Choti MA, Poston G. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol. 2012;4:283-301.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 99]  [Cited by in F6Publishing: 258]  [Article Influence: 21.5]  [Reference Citation Analysis (0)]
68.  Kawai T, Goumard C, Jeune F, Savier E, Vaillant JC, Scatton O. Laparoscopic liver resection for colorectal liver metastasis patients allows patients to start adjuvant chemotherapy without delay: a propensity score analysis. Surg Endosc. 2018;32:3273-3281.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 26]  [Cited by in F6Publishing: 31]  [Article Influence: 5.2]  [Reference Citation Analysis (0)]
69.  Mbah N, Agle SC, Philips P, Egger ME, Scoggins CR, McMasters KM, Martin RCG. Laparoscopic hepatectomy significantly shortens the time to postoperative chemotherapy in patients undergoing major hepatectomies. Am J Surg. 2017;213:1060-1064.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 16]  [Cited by in F6Publishing: 19]  [Article Influence: 2.7]  [Reference Citation Analysis (0)]
70.  Tabchouri N, Gayet B, Okumura S, Donatelli G, Beaussier M, Bennamoun M, Louvet C, Fuks D. Recurrence patterns after laparoscopic resection of colorectal liver metastases. Surg Endosc. 2018;32:4788-4797.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 8]  [Cited by in F6Publishing: 9]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
71.  Abu Hilal M, Underwood T, Zuccaro M, Primrose J, Pearce N. Short- and medium-term results of totally laparoscopic resection for colorectal liver metastases. Br J Surg. 2010;97:927-933.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 83]  [Cited by in F6Publishing: 89]  [Article Influence: 6.4]  [Reference Citation Analysis (0)]
72.  Beppu T, Wakabayashi G, Hasegawa K, Gotohda N, Mizuguchi T, Takahashi Y, Hirokawa F, Taniai N, Watanabe M, Katou M, Nagano H, Honda G, Baba H, Kokudo N, Konishi M, Hirata K, Yamamoto M, Uchiyama K, Uchida E, Kusachi S, Kubota K, Mori M, Takahashi K, Kikuchi K, Miyata H, Takahara T, Nakamura M, Kaneko H, Yamaue H, Miyazaki M, Takada T. Long-term and perioperative outcomes of laparoscopic vs open liver resection for colorectal liver metastases with propensity score matching: a multi-institutional Japanese study. J Hepatobiliary Pancreat Sci. 2015;22:711-720.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 107]  [Cited by in F6Publishing: 110]  [Article Influence: 12.2]  [Reference Citation Analysis (0)]
73.  Berardi G, Van Cleven S, Fretland ÅA, Barkhatov L, Halls M, Cipriani F, Aldrighetti L, Abu Hilal M, Edwin B, Troisi RI. Evolution of Laparoscopic Liver Surgery from Innovation to Implementation to Mastery: Perioperative and Oncologic Outcomes of 2,238 Patients from 4 European Specialized Centers. J Am Coll Surg. 2017;225:639-649.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 58]  [Cited by in F6Publishing: 51]  [Article Influence: 7.3]  [Reference Citation Analysis (0)]
74.  Chen TH, Yang HR, Jeng LB, Hsu SC, Hsu CH, Yeh CC, Yang MD, Chen WT. Laparoscopic Liver Resection: Experience of 436 Cases in One Center. J Gastrointest Surg. 2019;23:1949-1956.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 9]  [Cited by in F6Publishing: 9]  [Article Influence: 1.8]  [Reference Citation Analysis (0)]
75.  Cipriani F, Rawashdeh M, Ahmed M, Armstrong T, Pearce NW, Abu Hilal M. Oncological outcomes of laparoscopic surgery of liver metastases: a single-centre experience. Updates Surg. 2015;67:185-191.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 15]  [Cited by in F6Publishing: 16]  [Article Influence: 1.8]  [Reference Citation Analysis (0)]
76.  D’Hondt M, Willems E, Parmentier I, Pottel H, Verslype C, De Meyere C, Vansteenkiste F, Besselink M. Short term and oncologic outcomes of the first 250 Laparoscopic liver resections performed by a laparoscopically trained liver surgeon. HPB. 2018;20:S437.  [PubMed]  [DOI]  [Cited in This Article: ]
77.  Efanov M, Alikhanov R, Tsvirkun V, Kazakov I, Vankovich A, Kim P, Grendal K, Zamanov E. Minimally Invasive vs open hepatectomy for colorectal cancer liver metastases: comparative analysis of short-term results and survival with propensity score matching. HPB. 2018;20:S363.  [PubMed]  [DOI]  [Cited in This Article: ]
78.  Eveno C, Cailliez V, Lopezben S, Mirza DF, Kaiser G, Lapointe R, Mentha G, Pardo F, Adam R, Cherqui D. Role of laparoscopic approach in colorectal liver metastasis. An international multi-center data analysis using liver met survey. HPB. 2016;18:e61-62.  [PubMed]  [DOI]  [Cited in This Article: ]
79.  Hirokawa F, Hayashi M, Miyamoto Y, Asakuma M, Shimizu T, Komeda K, Inoue Y, Uchiyama K. Short- and long-term outcomes of laparoscopic vs open hepatectomy for small malignant liver tumors: a single-center experience. Surg Endosc. 2015;29:458-465.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 19]  [Cited by in F6Publishing: 19]  [Article Influence: 1.9]  [Reference Citation Analysis (0)]
80.  Inoue Y, Hayashi M, Tanaka R, Komeda K, Hirokawa F, Uchiyama K. Short-term results of laparoscopic vs open liver resection for liver metastasis from colorectal cancer: a comparative study. Am Surg. 2013;79:495-501.  [PubMed]  [DOI]  [Cited in This Article: ]
81.  Iwahashi S, Shimada M, Utsunomiya T, Imura S, Morine Y, Ikemoto T, Arakawa Y, Mori H, Kanamoto M, Yamada S. Laparoscopic hepatic resection for metastatic liver tumor of colorectal cancer: comparative analysis of short- and long-term results. Surg Endosc. 2014;28:80-84.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 41]  [Cited by in F6Publishing: 38]  [Article Influence: 3.5]  [Reference Citation Analysis (0)]
82.  Kasai M, Van Damme N, Berardi G, Geboes K, Laurent S, Troisi RI. The inflammatory response to stress and angiogenesis in liver resection for colorectal liver metastases: a randomized controlled trial comparing open vs laparoscopic approach. Acta Chir Belg. 2018;118:172-180.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 10]  [Cited by in F6Publishing: 9]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
83.  Kazaryan AM, Pavlik Marangos I, Rosseland AR, Røsok BI, Mala T, Villanger O, Mathisen O, Giercksky KE, Edwin B. Laparoscopic liver resection for malignant and benign lesions: ten-year Norwegian single-center experience. Arch Surg. 2010;145:34-40.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 82]  [Cited by in F6Publishing: 89]  [Article Influence: 6.4]  [Reference Citation Analysis (0)]
84.  Lewin JW, O'Rourke NA, Chiow AKH, Bryant R, Martin I, Nathanson LK, Cavallucci DJ. Long-term survival in laparoscopic vs open resection for colorectal liver metastases: inverse probability of treatment weighting using propensity scores. HPB (Oxford). 2016;18:183-191.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 42]  [Cited by in F6Publishing: 40]  [Article Influence: 5.0]  [Reference Citation Analysis (0)]
85.  Shelat VG, Cipriani F, Basseres T, Armstrong TH, Takhar AS, Pearce NW, AbuHilal M. Pure laparoscopic liver resection for large malignant tumors: does size matter? Ann Surg Oncol. 2015;22:1288-1293.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 49]  [Cited by in F6Publishing: 50]  [Article Influence: 5.6]  [Reference Citation Analysis (0)]
86.  Topal B, Tiek J, Fieuws S, Aerts R, Van Cutsem E, Roskams T, Prenen H. Minimally invasive liver surgery for metastases from colorectal cancer: oncologic outcome and prognostic factors. Surg Endosc. 2012;26:2288-2298.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 15]  [Cited by in F6Publishing: 14]  [Article Influence: 1.2]  [Reference Citation Analysis (0)]
87.  Vibert E, Perniceni T, Levard H, Denet C, Shahri NK, Gayet B. Laparoscopic liver resection. Br J Surg. 2006;93:67-72.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 273]  [Cited by in F6Publishing: 295]  [Article Influence: 16.4]  [Reference Citation Analysis (0)]
88.  Kwon IS, Yun SS, Lee DS, Kim HJ. Laparoscopic liver resection for malignant liver tumors, why not more? J Korean Surg Soc. 2012;83:30-35.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 12]  [Cited by in F6Publishing: 12]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
89.  Cugat Andorrà E, Herrero Fonollosa E, García Domingo MI, Camps Lasa J, Carvajal López F, Rodríguez Campos A, Cirera Nogueras L, Fernández Plana J, de Marcos Izquierdo JÁ, Paraira Beser M, San Martín Elizaincín M. [Results after laparoscopic liver resection: an appropriate option in malignant disease]. Cir Esp. 2013;91:510-516.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 4]  [Cited by in F6Publishing: 4]  [Article Influence: 0.4]  [Reference Citation Analysis (0)]
90.  Abu Hilal M, Di Fabio F, Teng MJ, Lykoudis P, Primrose JN, Pearce NW. Single-centre comparative study of laparoscopic vs open right hepatectomy. J Gastrointest Surg. 2011;15:818-823.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 73]  [Cited by in F6Publishing: 78]  [Article Influence: 6.0]  [Reference Citation Analysis (0)]
91.  Montalti R, Scuderi V, Patriti A, Vivarelli M, Troisi RI. Robotic vs laparoscopic resections of posterosuperior segments of the liver: a propensity score-matched comparison. Surg Endosc. 2016;30:1004-1013.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 75]  [Cited by in F6Publishing: 86]  [Article Influence: 9.6]  [Reference Citation Analysis (0)]
92.  Portigliotti L, Fuks D, Slivca O, Bourdeaux C, Nomi T, Bennamoun M, Gentilli S, Gayet B. A comparison of laparoscopic resection of posterior segments with formal laparoscopic right hepatectomy for colorectal liver metastases: a single-institution study. Surg Endosc. 2017;31:2560-2565.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 10]  [Cited by in F6Publishing: 10]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
93.  Scuderi V, Barkhatov L, Montalti R, Ratti F, Cipriani F, Pardo F, Tranchart H, Dagher I, Rotellar F, Abu Hilal M, Edwin B, Vivarelli M, Aldrighetti L, Troisi RI. Outcome after laparoscopic and open resections of posterosuperior segments of the liver. Br J Surg. 2017;104:751-759.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 56]  [Cited by in F6Publishing: 69]  [Article Influence: 9.9]  [Reference Citation Analysis (0)]
94.  Efanov M, Granov D, Alikhanov R, Rutkin I, Tsvirkun V, Kazakov I, Vankovich A, Koroleva A, Kovalenko D. Expanding indications for laparoscopic parenchyma-sparing resection of posterosuperior liver segments in patients with colorectal metastases: comparison with open hepatectomy for immediate and long-term outcomes. Surg Endosc. 2021;35:96-103.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 8]  [Cited by in F6Publishing: 8]  [Article Influence: 2.0]  [Reference Citation Analysis (0)]
95.  Okumura S, Tabchouri N, Leung U, Tinguely P, Louvet C, Beaussier M, Gayet B, Fuks D. Laparoscopic Parenchymal-Sparing Hepatectomy for Multiple Colorectal Liver Metastases Improves Outcomes and Salvageability: A Propensity Score-Matched Analysis. Ann Surg Oncol. 2019;26:4576-4586.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 17]  [Cited by in F6Publishing: 18]  [Article Influence: 3.6]  [Reference Citation Analysis (0)]
96.  Jung KU, Kim HC, Cho YB, Kwon CH, Yun SH, Heo JS, Lee WY, Chun HK. Outcomes of simultaneous laparoscopic colorectal and hepatic resection for patients with colorectal cancers: a comparative study. J Laparoendosc Adv Surg Tech A. 2014;24:229-235.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 26]  [Cited by in F6Publishing: 27]  [Article Influence: 2.7]  [Reference Citation Analysis (0)]
97.  van der Poel MJ, Tanis PJ, Marsman HA, Rijken AM, Gertsen EC, Ovaere S, Gerhards MF, Besselink MG, D'Hondt M, Gobardhan PD. Laparoscopic combined resection of liver metastases and colorectal cancer: a multicenter, case-matched study using propensity scores. Surg Endosc. 2019;33:1124-1130.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 12]  [Cited by in F6Publishing: 9]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
98.  Cervantes B, Gayet B, Frosio F, Tabchouri N, Bennamoun M, Alexandra N, Louvet C, Fuks D. The smallest colorectal liver metastasis size as a prognosis factor after laparoscopic liver resection. Ann Oncol. 2019;30:v213.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 2]  [Cited by in F6Publishing: 2]  [Article Influence: 0.4]  [Reference Citation Analysis (0)]
99.  de Haas RJ, Rahy Martin AC, Wicherts DA, Azoulay D, Castaing D, Adam R. Long-term outcome in patients with adrenal metastases following resection of colorectal liver metastases. Br J Surg. 2009;96:935-940.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 12]  [Cited by in F6Publishing: 13]  [Article Influence: 0.9]  [Reference Citation Analysis (0)]
100.  Jones C, Badger SA, Stevenson M, Diamond T, McKie LD, Taylor MA, Wilson RH, Lynch TB. PET-CT as a predictor of outcome in resectable colorectal liver metastases. Eur J Gastroenterol Hepatol. 2014;26:466-472.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 5]  [Cited by in F6Publishing: 5]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
101.  Ratti F, Fuks D, Cipriani F, Gayet B, Aldrighetti L. Timing of Perioperative Chemotherapy Does Not Influence Long-Term Outcome of Patients Undergoing Combined Laparoscopic Colorectal and Liver Resection in Selected Upfront Resectable Synchronous Liver Metastases. World J Surg. 2019;43:3110-3119.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 11]  [Cited by in F6Publishing: 11]  [Article Influence: 2.8]  [Reference Citation Analysis (0)]
102.  Nierop PMH, Höppener DJ, van der Stok EP, Galjart B, Buisman FE, Balachandran VP, Jarnagin WR, Kingham TP, Allen PJ, Shia J, Vermeulen PB, Groot Koerkamp B, Grünhagen DJ, Verhoef C, D'Angelica MI. Histopathological growth patterns and positive margins after resection of colorectal liver metastases. HPB (Oxford). 2020;22:911-919.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 16]  [Cited by in F6Publishing: 15]  [Article Influence: 3.8]  [Reference Citation Analysis (0)]